Curaleaf Holdings (OTC) (TSE:CURA) has released an update.
Curaleaf Holdings has reported a modest year-over-year revenue growth of 2% in the first quarter of 2024, with earnings of $339 million and an adjusted gross margin increase to 48%. The company also improved its adjusted EBITDA margin by 40 basis points to 23%, yielding $77 million, while operating cash flow reached $46 million and free cash flow stood at $33 million. This performance comes amid Curaleaf’s strategic shift from a multi-state to a multi-country cannabis operator, emphasizing its growing global presence and long-term growth prospects.
For further insights into TSE:CURA stock, check out TipRanks’ Stock Analysis page.
